Market foothold ISTA was a rapidly growing branded eye care specialist with a U.S. sales force targeting ophthalmologists, optometrists and allergists, indicating strong relationships and entry points for eye care product introductions.

Acquisition leverage ISTA has been integrated into Bausch + Lomb and subsequently Valeant, suggesting sales opportunities through a broader corporate distribution network, cross-sell potential, and access to larger customer bases via established channels.

Product expansion Key products cover postoperative inflammation and pain, allergic conjunctivitis, glaucoma, and ocular spreading, presenting multiple adjacent addressable needs for eye care physicians and potential line extensions or reformulations.

Financial momentum Recent publicized growth signals for the parent entity (revenue increases, solid EBITDA) indicate a favorable financial backdrop for investments in new product launches, market expansion, or partnerships in eye health.

Tech and ops base Technology stack including Kubernetes, SAP HANA, and enterprise platforms signals scalable operations and data-driven sales strategies, enabling targeted marketing, higher forecast accuracy, and efficient field execution.